Standout Papers

STING Agonists as Cancer Therapeutics 2021 2026 2022 2024269
  1. STING Agonists as Cancer Therapeutics (2021)
    Afsaneh Amouzegar, Manoj Chelvanambi et al. Cancers

Immediate Impact

9 by Nobel laureates 13 from Science/Nature 66 standout
Sub-graph 1 of 22

Citing Papers

The balance of STING signaling orchestrates immunity in cancer
2024 Standout
De novo protein design—From new structures to programmable functions
2024 Standout
1 intermediate paper

Works of J Filderman being referenced

Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonists
2023
Enhanced tumor-targeting selectivity by modulating bispecific antibody binding affinity and format valence
2017
and 2 more

Author Peers

Author Last Decade Papers Cites
J Filderman 392 224 184 7 509
Elisa Rosati 284 132 155 14 469
Li-Chung Tsao 266 166 133 15 509
Meredith Slota 304 255 141 15 427
Wilhem Leconet 174 228 139 12 503
Floriane Noël 266 149 221 10 503
Jana Václavíková 276 118 121 8 570
Dries Renmans 293 243 249 9 494
Kristen Hopson 370 219 358 8 525
Katy J. McCann 308 178 242 16 554
Nadja Salomon 267 174 323 9 487

All Works

Loading papers...

Rankless by CCL
2026